Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Mechanisms regulating regional localization of inflammation during CNS autoimmunity.
Fatigue and its association with sleep disorders, depressive symptoms and anxiety in patients with multiple sclerosis.
Autonomic dysfunction in multiple sclerosis presenting with postural orthostatic tachycardia.
Cognitive impairment and optic nerve axonal loss in patients with clinically isolated syndrome.
A population-based study of fall risk factors among people with multiple sclerosis in Stockholm county.
Rapidly progressive amyotrophic lateral sclerosis initially masquerading as a demyelinating neuropathy.
Pathological correlates of magnetic resonance imaging texture heterogeneity in multiple sclerosis.
Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis.
Optimizing therapy early in multiple sclerosis: An evidence-based view.
Gait variability in multiple sclerosis: a better falls predictor than EDSS in patients with low disability.
Age of Onset as a Moderator of Cognitive Decline in Pediatric-Onset Multiple Sclerosis.
Quantification of Th1 and Th17 Cells with Intracellular Staining Following PMA/Ionomycin Stimulation.
Improving Multiple Sclerosis Plaque Detection Using a Semiautomated Assistive Approach.
Acute effects of walking, cycling, and yoga exercise on cognition in persons with relapsing-remitting multiple sclerosis without impaired cognitive processing speed.
Absence of Multiple Sclerosis and Demyelinating Diseases among Lacandonians, a Pure Amerindian Ethnic Group in Mexico.
Fatigue in childhood multiple sclerosis.
Microcystic macular oedema confirmed, but not specific for multiple sclerosis.
Alemtuzumab for multiple sclerosis.
Retinal thickness in pediatric multiple sclerosis.
Functional Cognitive Disorder: A Common Cause of Subjective Cognitive Symptoms.
Exploratory validation of a multidimensional power wheelchair outcomes toolkit.
A molecular view of multiple sclerosis and experimental autoimmune encephalitis: What can we learn from the epitope data?
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
Corticosteroid-responsive torticollis as a presenting symptom of multiple sclerosis.
Chromatic visual evoked potentials in young patients with demyelinating disease.
Pages
« first
‹ previous
…
374
375
376
377
378
379
380
381
382
…
next ›
last »